.png)
Most health and wellness marketing campaigns die in approval limbo. A campaign that took weeks to develop sits waiting for medical, legal, and regulatory sign-off while market windows close, seasonal moments pass, and competitors capture the audience.
For regulated industries like cannabis, hemp, nicotine, and wellness, this problem compounds. Platform restrictions already limit where brands can advertise. Claim-sensitive messaging requires careful language. State-specific rules demand multiple campaign versions. Adding a broken internal approval process to these external constraints makes growth nearly impossible.

Medical, Legal, and Regulatory (MLR) review is a cross-functional process for assessing promotional materials. Medical reviewers examine scientific accuracy, legal reviewers assess obligations and risk, and regulatory reviewers evaluate product-specific promotional requirements.
Formal MLR committees are common in pharmaceutical marketing. Supplement and wellness businesses may use smaller review teams, but still need appropriate substantiation and oversight. Review structure should match the product, claims, channels, and jurisdiction. A campaign can also require re-review when distribution changes, even if its headline stays identical.
Common bottlenecks include:
Timelines vary substantially; a single industry-wide 15-to-60-day average is not established by the draft's supporting material.
Healthcare and wellness promotions can involve overlapping rules. The FDA regulates products and certain promotional claims, while the FTC requires advertising to be truthful and supported by appropriate evidence. HIPAA applies to covered entities and business associates when protected health information is involved; it does not automatically govern every wellness brand.
The FTC's health-products guidance emphasizes competent and reliable scientific evidence, including for implied claims. Testimonials alone do not substantiate product efficacy. Prescription drug promotion additionally must communicate benefits and risks accurately and fairly under FDA oversight.
Platform policies, state restrictions, age requirements, and product eligibility add further review needs. These differences make a shared claims library and product-specific routing more useful than one universal approval checklist. Teams should record which regulations and platform policies apply to each asset, rather than assume a single approval carries across regions.
.png)
Where appropriate, parallel review lets medical, legal, and regulatory reviewers examine the same controlled version concurrently. Final decisions still require designated authority, documented responses, and resolution of substantive objections.
A claims library can store previously reviewed statements alongside supporting studies, approved products, permitted channels, and expiration or review dates.
Claims such as “supports healthy immune function” still require evidence appropriate to their meaning. Reusing approved text alongside a new image, testimonial, or headline can change the overall claim. Libraries reduce repeated research; they do not confer blanket approval on new creative.
A review-ready package should contain:
A consistent intake checklist allows reviewers to focus on substance instead of chasing missing files. Submissions should also specify whether assets are part of a broader campaign, since a landing page, social post, and email can collectively create an implied claim.
AI tools can flag missing references, inconsistent disclaimers, duplicate content, and formatting errors before human review. One software vendor has publicized an 86% reduction in submission errors from its platform, but that is a vendor-reported result, not a general industry benchmark.
AI cannot reliably determine every implied claim or product-specific restriction. Medical, legal, and regulatory reviewers remain responsible for decisions. Automated alerts also require a defined owner so that flagged claims are corrected rather than simply moved to a different review queue.
Compliance input at the briefing stage helps teams identify viable channels, evidence needs, and claim limits before producing creative. Herb Agency's marketing approach emphasizes regulated-market planning, while final product-specific approvals remain with the responsible organization.
Organizations may adapt three review tiers:
These are internal workflow categories, not exemptions from FDA or FTC requirements. The complete advertisement remains subject to review. Approval status should include a version identifier and a re-review trigger for changes to evidence, visuals, or targeting.
Develop channel-specific messaging guidelines, templates with reviewed elements, and a route for urgent or novel claims. Train creative teams to identify unsupported efficacy promises, misleading comparisons, and disclosures requiring attention.
Mobile privacy features, browser settings, and platform policies complicate cross-site tracking. Chrome did not complete the previously proposed universal third-party-cookie phaseout, so cookie deprecation should not be treated as a completed event.
Owned audiences can reduce reliance on paid platforms, but data collection and promotional use still require appropriate permissions. Subscriber consent, privacy notices, and retention policies should be documented before contact information enters automation tools. Healthcare organizations handling PHI may also need HIPAA marketing authorizations; an ordinary email opt-in is not always sufficient.
Herb Mail supports consent-based audience development from website visitors. Herb Reactivate helps businesses assess inactive contact records for possible re-engagement, subject to valid permissions and deliverability requirements.
.png)
Health and wellness ads can be restricted by product type, claim, age group, or destination page. Platform approval does not establish legal compliance, and inconsistent approvals should not be treated as permission to bypass policy.
Herb Agency's services include compliance-aware channel planning for eligible regulated products.
Educational material can answer consumer questions, support search visibility, and provide context before purchase. It still requires claim substantiation when the overall message implies a health benefit.
The FTC's endorsement guidance also addresses material connections and advertiser responsibility for endorsements. Content should inform decisions, not use educational framing to evade claim rules.
Websites, permission-based email lists, and useful content libraries give brands greater control over customer communications than rented ad placements. They still depend on privacy compliance, search visibility, and continued subscriber interest.
Organic search may support demand capture over time, although rankings and traffic are not guaranteed. Local SEO is relevant to eligible physical retailers and service businesses.
.png)
Marketing teams need to measure performance without confusing engagement with revenue or treating all assisted orders as directly attributable sales. Consistent definitions help marketing, finance, and compliance teams evaluate results. Dashboards should disclose their attribution rules and reporting windows so assisted conversions are not accidentally presented as causal proof.
Herb Dashboard supports campaign analytics and ROI measurement. Herb UGC also helps assess content engagement and conversion contribution, subject to the data available and appropriate permissions.
Direct mail can provide another customer touchpoint when digital retargeting is unavailable. However, using browsing activity or addresses for promotional mail still requires review of privacy laws, product eligibility, and applicable marketing restrictions.
An eight-week rollout can serve as a planning example for a small or moderately complex approval process; it is not a guaranteed implementation timeline. Larger organizations may require additional legal, technical, and training work.
Dedicated reviewer time, complete submission requirements, clear escalation, and agreed decision authority improve predictability. Parallel review is useful when responsibilities permit it, but no workflow design should override mandatory specialist review.
The most common delays involve submission quality, decision routing, and maintenance rather than an absence of software.
.png)
Herb Agency combines cannabis and hemp experience with services for broader restricted markets. Its role is to support campaign planning, content, audience growth, and measurement—not to replace a brand's medical, legal, or regulatory approval authority.
Herb Paid Media supports eligible channel selection, targeting, creative strategy, and performance optimization. The Arete Hemp campaign reported 617,207 programmatic impressions, 2,513 clicks, and $125,558 in influenced revenue. These are hemp-specific results rather than proof of pharmaceutical MLR capabilities.
Herb Editorial creates educational articles, sponsored features, and product content for appropriate review. Distribution through Herb.co's cannabis-oriented media audience is particularly relevant to cannabis and hemp brands, not a guaranteed wellness placement.
Herb Mail helps build consent-based subscriber relationships. Herb Reactivate can support re-engagement of existing contacts where permissions and provider policies allow.
Herb Dashboard reports email, editorial, and paid-media activity. Herb UGC helps measure content engagement and its relationship to traffic and conversions, without treating influenced revenue as equivalent to direct attribution.
Herb Postal supports trackable offline outreach for qualifying products and audiences. The Indacloud campaign reported a 99.20% delivery rate and 3.41% QR scan rate; the results are illustrative, not guaranteed.
Herb Agency's services can complement internal MLR processes by preparing campaigns for review and measuring approved activity. Organizations retain responsibility for claim substantiation and final approval.
Herb Agency offers interconnected marketing capabilities for brands working within restricted advertising and claims environments:
Brands can book a strategy call to discuss eligible growth initiatives and the internal approvals their campaigns require.